Oral Medications For Skin Diseases: 15 Essential Options
Comprehensive guide to oral drugs for treating various skin conditions, including antifungals, immunosuppressants, and retinoids.

Oral medications are essential for managing moderate to severe skin diseases when topical treatments prove inadequate. These drugs target underlying inflammatory, infectious, or hyperproliferative processes in conditions such as psoriasis, eczema, fungal infections, and autoimmune bullous disorders. Selection depends on disease severity, patient factors, and potential side effects.
Immunosuppressants and Anti-inflammatory Agents
Drugs like methotrexate modulate immune responses and reduce inflammation in chronic skin conditions. Methotrexate, a folate antagonist, is widely used for psoriasis and other inflammatory dermatoses.
Methotrexate
Methotrexate treats moderate to severe psoriasis, atopic dermatitis, pityriasis rubra pilaris, pompholyx, chronic actinic dermatitis, cutaneous T-cell lymphoma, pityriasis lichenoides, chronic spontaneous urticaria, immunobullous diseases (e.g., bullous pemphigoid, pemphigus), morphoea, and lupus erythematosus. It is suitable for adults and children over 3 years.
Improvement typically begins within 6-8 weeks, with maximum effects in 5-6 months. In psoriasis, 50-70% of patients achieve a 75% reduction in PASI score.
Mechanisms: Anti-inflammatory via adenosine increase; immune modulation by reducing T-cell homing, neutrophil activity, and cytokines (TNF-α, IL-10, IL-12); antimetabolite action inhibiting DNA synthesis at higher doses.
Dosing: Weekly 2.5-30 mg, commonly 15 mg, adjusted for renal function, age, and weight. Start low (2.5-5 mg) in elderly (>75 years) or low body weight. Take as single dose or split; after meals or bedtime if nauseous. Subcutaneous injections for GI intolerance.
Folic acid supplementation (e.g., 5 mg weekly) mitigates side effects like stomatitis.
Side Effects: Nausea, fatigue, hepatotoxicity (monitor LFTs), bone marrow suppression (CBC monitoring), infections (e.g., shingles), pulmonary fibrosis (rare). Contraindicated in pregnancy, alcoholism, active infection.
Oral Antifungal Medications
Oral antifungals are reserved for extensive, severe, or topical-resistant fungal infections of skin, hair, and nails. Common agents include triazoles (itraconazole, fluconazole, ketoconazole) and allylamines (terbinafine).
Itraconazole (Sporanox™)
Broad-spectrum for dermatophytes, yeasts, and molds. Take after fatty meal with acidic drink. Dosing varies: e.g., 200 mg/day for 7 days for tinea corporis; pulse therapy for onychomycosis (200 mg twice daily for 1 week/month, 2-3 pulses).
Drug interactions: Reduced by CYP3A4 inducers (e.g., rifampicin). Avoid in pregnancy.
Fluconazole (Diflucan™)
Effective for candidiasis and dermatophyte infections (not registered for nails in NZ). Dosing: 50-400 mg weekly for 2-12 months depending on site.
Contraindicated with cisapride; avoid in pregnancy, heart/renal disease. Side effects: nausea, rash, liver enzyme elevation.
Ketoconazole (Nizoral™)
For resistant infections: 200 mg daily after food. Effective against yeasts and dermatophytes.
Terbinafine
Allylamine for dermatophyte infections, especially onychomycosis: 250 mg daily for 6-12 weeks.
Antifungal Resistance: Increasing in azoles and allylamines, especially in immunosuppressed patients or from regions like India. Use culture and MIC testing for resistant cases.
Retinoids
Systemic retinoids like acitretin and alitretinoin treat disorders of keratinization and inflammation.
Acitretin
Used for psoriasis (esp. pustular, erythrodermic), ichthyosis, Darier disease, palmoplantar pustulosis. Dosing: 10-50 mg daily, maintenance 25-30 mg. Teratogenic; avoid pregnancy for 3 years post-treatment.
Side effects: Hyperlipidemia, hepatotoxicity, mucocutaneous dryness. Monitor lipids and LFTs.
Alitretinoin
For severe chronic hand eczema unresponsive to topicals. 30 mg daily for 24 weeks.
Antivirals
Aciclovir
Oral for herpes zoster (shingles), herpes simplex. Dosing: 800 mg 5x/day for 7 days (shingles); 200-400 mg 3-5x/day for 5-10 days (HSV). Reduces duration and severity.
Antimalarials
Hydroxychloroquine, chloroquine for lupus erythematosus, lichen planopilaris, sarcoidosis. Dosing: Hydroxychloroquine 200-400 mg daily. Retinopathy risk requires baseline and periodic eye exams.
Antiandrogens
Spironolactone, cyproterone acetate for acne, hirsutism in women. Spironolactone 50-200 mg daily; monitor potassium.
Other Agents
- Abrocitinib: JAK inhibitor for atopic dermatitis.
- Amitriptyline: For neuropathic itch/pruritus.
- Acne treatments: Isotretinoin for severe nodulocystic acne (0.5-1 mg/kg/day, 4-6 months).
Monitoring Immune-Modulating Drugs
Essential for long-term use (e.g., methotrexate, azathioprine, ciclosporin). Monitor for hepatotoxicity, myelosuppression, infections, skin cancer.
| Drug | Baseline Tests | Ongoing Monitoring |
|---|---|---|
| Methotrexate | CBC, LFTs, renal, hepatitis serology | Monthly CBC/LFTs x3, then 2-3 monthly |
| Ciclosporin | BP, renal, lipids, LFTs | Weekly BP/renal first month, then monthly |
| Azathioprine | TPMT, CBC, LFTs | Monthly CBC/LFTs |
Full body skin exams for skin cancer risk on long-term therapy.
Frequently Asked Questions (FAQs)
Q: When are oral antifungals indicated?
A: For extensive/severe fungal infections resistant to topicals, such as widespread tinea or onychomycosis.
Q: How soon does methotrexate work for psoriasis?
A: Benefits in 6-8 weeks; peak effect 5-6 months.
Q: What are common methotrexate side effects?
A: Nausea, liver issues, infections; mitigated by folic acid and monitoring.
Q: Is monitoring required for retinoids?
A: Yes, lipids, LFTs for acitretin; pregnancy tests for females.
Q: Can oral meds cure skin diseases?
A: Many control symptoms; e.g., antifungals cure infections, but psoriasis often requires maintenance.
Safety Considerations
Pregnancy contraindications common (methotrexate, retinoids, antifungals). Drug interactions abound (e.g., itraconazole with statins). Always consult datasheets and national formularies like NZF, BNF.
References
- Methotrexate – DermNet New Zealand — Dr Amanda Oakley et al., DermNet NZ. 2015-12. https://sussexcds.co.uk/wp-content/uploads/2019/10/Methotrexate_NZDermNet.pdf
- Oral Antifungal Drugs – DermNet — DermNet NZ. 2024. https://dermnetnz.org/cme/fungal-infections/oral-antifungal-drugs
- Oral Antifungal Medication – DermNet — DermNet NZ. 2024. https://dermnetnz.org/topics/oral-antifungal-medication
- Oral Medications for Skin Diseases – DermNet — DermNet NZ. 2024-07. https://dermnetnz.org/topics/oral-medications-for-skin-diseases
- Monitoring Immune-Modulating Drugs – DermNet — DermNet NZ. 2024. https://dermnetnz.org/topics/monitoring-immune-modulating-drugs-used-in-dermatology
- Dermatological Guide for Primary Care Physicians — PMC/NCBI. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC11188824/
Read full bio of Sneha Tete
















